Grant Details

Grant Number: |
5R01CA075971-11 Interpret this number |

Primary Investigator: |
Betensky, Rebecca |

Organization: |
Harvard School Of Public Health |

Project Title: |
Statistical Methods for Analysis of Failure Time Data |

Fiscal Year: |
2009 |

Abstract

DESCRIPTION (provided by applicant): The goal of this application is to develop statistical methods for the analysis of failure time data in the presence of missing diagnoses or classification, missing observation time and progression measurement, and missing segments of the target population. These types of missingness are not individual-specific, but rather are characteristic of the entire study population. That is, all subjects are missing a histologically-based diagnosis, or all subjects are missing continuous-valued, continuous-time measurements of progression, or all subjects of a certain type are missing from the study population. These three dimensions of population- wide missingness encompass a broad range of real problems that I have encountered in studies of brain tumors, schwannomas, Multiple Sclerosis (MS), and coronary heart disease (CHD). The brain tumor and schwannoma studies measure several histologic features, with the goal of refining diagnoses to be more prognostic for clinical outcomes. The MS study features a failure endpoint that is defined by a discrete time ordinal longitudinal process. This is common in many cancer studies, which have scored endpoints such as radiologic progression and performance status. The CHD study typifies an emerging common design in which prospective cohorts are sampled mid-study for genetic analysis. This is commonly done to investigate genetic associations with various cancers, as well. An array of statistical methods, including Bayesian and frequentist latent class models, transitional models for ordinal processes, and pseudo likelihood estimation for a biased sample, are used to address these problems. Relevance: This research aims to provide improved statistical methods for the design and analysis of clinical and laboratory studies of cancer. The methods may lead to faster discovery of cancer genes and effective treatments and to better understanding of disease progression through more efficient use of resources.

Publications

**A Non-parametric Maximum Likelihood Estimator For Bivariate Interval Censored Data**

**Authors:**Betensky R.A. , Finkelstein D.M. .

**Source:**Statistics In Medicine, 1999-11-30 00:00:00.0; 18(22), p. 3089-100.

**PMID:**10544308

Related Citations

**An Extension Of Kendall's Coefficient Of Concordance To Bivariate Interval Censored Data**

**Authors:**Betensky R.A. , Finkelstein D.M. .

**Source:**Statistics In Medicine, 1999-11-30 00:00:00.0; 18(22), p. 3101-9.

**PMID:**10544309

Related Citations

**Multiple Imputation For Simple Estimation Of The Hazard Function Based On Interval Censored Data**

**Authors:**Bebchuk J.D. , Betensky R.A. .

**Source:**Statistics In Medicine, 2000-02-15 00:00:00.0; 19(3), p. 405-19.

**PMID:**10649305

Related Citations

**Using Conditional Logistic Regression To Fit Proportional Odds Models To Interval Censored Data**

**Authors:**Rabinowitz D. , Betensky R.A. , Tsiatis A.A. .

**Source:**Biometrics, 2000 Jun; 56(2), p. 511-8.

**PMID:**10877311

Related Citations

**Approximating The Distribution Of Maximally Selected Mcnemar's Statistics**

**Authors:**Rabinowitz D. , Betensky R.A. .

**Source:**Biometrics, 2000 Sep; 56(3), p. 897-902.

**PMID:**10985234

Related Citations

**Maximally Selected Chi2 Statistics For K X 2 Tables**

**Authors:**Betensky R.A. , Rabinowitz D. .

**Source:**Biometrics, 1999 Mar; 55(1), p. 317-20.

**PMID:**11318175

Related Citations

**The Use Of Frailty Hazard Models For Unrecognized Heterogeneity That Interacts With Treatment: Considerations Of Efficiency And Power**

**Authors:**Li Y. , Betensky R.A. , Louis D.N. , Cairncross J.G. .

**Source:**Biometrics, 2002 Mar; 58(1), p. 232-6.

**PMID:**11890320

Related Citations

**Local Likelihood Analysis Of The Latency Distribution With Interval Censored Intermediate Events**

**Authors:**Bebchuk J.D. , Betensky R.A. .

**Source:**Statistics In Medicine, 2002-11-30 00:00:00.0; 21(22), p. 3475-91.

**PMID:**12407685

Related Citations

**Analysis Of A Molecular Genetic Neuro-oncology Study With Partially Biased Selection**

**Authors:**Betensky R.A. , Louis D.N. , Cairncross J.G. .

**Source:**Biostatistics (oxford, England), 2003 Apr; 4(2), p. 167-78.

**PMID:**12925514

Related Citations

**Hazard Regression For Interval-censored Data With Penalized Spline**

**Authors:**Cai T. , Betensky R.A. .

**Source:**Biometrics, 2003 Sep; 59(3), p. 570-9.

**PMID:**14601758

Related Citations

**Power Calculations For Familial Aggregation Studies**

**Authors:**Rabbee N. , Betensky R.A. .

**Source:**Genetic Epidemiology, 2004 May; 26(4), p. 316-27.

**PMID:**15095391

Related Citations

**Statistical Considerations For Immunohistochemistry Panel Development After Gene Expression Profiling Of Human Cancers**

**Authors:**Betensky R.A. , Nutt C.L. , Batchelor T.T. , Louis D.N. .

**Source:**The Journal Of Molecular Diagnostics : Jmd, 2005 May; 7(2), p. 276-82.

**PMID:**15858152

Related Citations

**Hospital Volume Versus Outcome: An Unusual Example Of Bivariate Association**

**Authors:**Betensky R.A. , Christian C.K. , Gustafson M.L. , Daley J. , Zinner M.J. .

**Source:**Biometrics, 2006 Jun; 62(2), p. 598-604.

**PMID:**16918925

Related Citations